Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-(TERT-BUTYL)-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID, also known as tBMPA, is a white solid chemical compound belonging to the class of pyrazole carboxylic acids. With a molecular formula of C10H16N2O2 and a molecular weight of 192.25 g/mol, tBMPA is recognized for its potential applications in the pharmaceutical industry as a building block for synthesizing various drugs and bioactive compounds. Its structure includes a tert-butyl group and a carboxylic acid functionality, which allows for further derivatization and modification to create new compounds with tailored properties. tBMPA has also garnered interest due to its potential antimicrobial and anticancer activities, making it a promising candidate for research and development in the field of medicinal chemistry.

175277-11-9

Post Buying Request

175277-11-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

175277-11-9 Usage

Uses

Used in Pharmaceutical Industry:
3-(TERT-BUTYL)-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID is used as a building block for the synthesis of various drugs and bioactive compounds, leveraging its chemical structure for the development of new pharmaceutical agents.
Used in Antimicrobial Applications:
In the field of antimicrobial research, 3-(TERT-BUTYL)-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID is studied for its potential antimicrobial activities, offering a foundation for the creation of new antimicrobial agents to combat resistant strains of bacteria.
Used in Anticancer Research:
3-(TERT-BUTYL)-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID is utilized in anticancer research for its potential to inhibit the growth of cancer cells, providing a basis for the development of novel therapeutics against various types of cancer.
Used in Chemical Derivatization:
3-(TERT-BUTYL)-1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID is used as a starting material for chemical derivatization, enabling the modification of its structure to create new compounds with specific properties for various applications in the chemical and pharmaceutical industries.

Check Digit Verification of cas no

The CAS Registry Mumber 175277-11-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,7 and 7 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 175277-11:
(8*1)+(7*7)+(6*5)+(5*2)+(4*7)+(3*7)+(2*1)+(1*1)=149
149 % 10 = 9
So 175277-11-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H14N2O2/c1-9(2,3)7-5-6(8(12)13)11(4)10-7/h5H,1-4H3,(H,12,13)

175277-11-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(tert-Butyl)-1-methyl-1H-pyrazole-5-carboxylic acid

1.2 Other means of identification

Product number -
Other names 5-tert-butyl-2-methylpyrazole-3-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:175277-11-9 SDS

175277-11-9Relevant articles and documents

Sulfone compounds which modulate the CB2 receptor

-

Page/Page column 39-40, (2012/03/08)

Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating p

SUBSTITUTED BENZIMDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS

-

, (2012/08/27)

The present invention is directed to benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia

SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS

-

, (2011/10/02)

The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.

SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR

-

Page/Page column 66, (2009/12/23)

Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating p

PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE and INFLAMMATORY DISEASES

-

Page/Page column 43-44, (2009/07/17)

The present invention relates to compounds that are inhibitors of PDElA, a phosphodiesterase that is involved in the modulation of the degradation of cartilage, joint degeneration and diseases involving such degradation and/or inflammation, and particular

Utility of Complementary Molecular Reactivity and Molecular Recognition (CMR/R) Technology and Polymer-Supported Reagents in the Solution-Phase Synthesis of Heterocyclic Carboxamides

Parlow, John J.,Mischke, Deborah A.,Woodard, Scott S.

, p. 5908 - 5919 (2007/10/03)

The use of our recently reported chemical library purification strategy in the development of a herbicidal lead, N-(3-benzoylphenyl)-3-(1,1-dimethylethyl)-1-methyl-1H-pyrazole-5-carboxamide (3), is described. The approach applying fundamental properties of complementary molecular reactivity and molecular recognition (CMR/R) as the basis for a general purification strategy was utilized. Polymeric reagents were used in the synthesis to generate reactive species involved in product formation, and complementary molecular reactivity/molecular recognition polymer 8 (CMR/R polymer 8) was used in the solution-phase syntheses of building blocks, primary libraries, and lead refinement libraries. An extension of the CMR/R methodology was applied, utilizing a sequestration enabling reagent (SER), transforming a reactant into an electrophilic species sequestrable by CMR/R polymer 8. This library purification strategy enabled rapid lead generation and lead refinement to afford herbicide 27o. The CMR/R solid-phase purification technique enabled a simple, general, and powerful protocol, eliminating the usual tedious and time-consuming methods required for solution-phase product purification. The result was the synthesis of hundreds of compounds, prepared in a relatively short time, leading to a compound with a 4-fold improvement in herbicidal activity over the initial lead.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 175277-11-9